CARCINOMA BRONCHIOGENIC STAGE III

Clinical trials for CARCINOMA BRONCHIOGENIC STAGE III explained in plain language.

Never miss a new study

Get alerted when new CARCINOMA BRONCHIOGENIC STAGE III trials appear

Sign up with your email to follow new studies for CARCINOMA BRONCHIOGENIC STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can an immunotherapy cocktail shrink inoperable lung tumors?

Disease control Completed

This phase II trial is testing whether adding the immunotherapy drug atezolizumab to standard chemotherapy and radiation can help people with stage III non-small cell lung cancer that cannot be surgically removed. About 50 participants will receive the combination treatment, and …

Matched conditions: CARCINOMA BRONCHIOGENIC STAGE III

Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control

Last updated Jul 24, 2026 00:00 UTC

CARCINOMA BRONCHIOGENIC STAGE III

Get alerted when new CARCINOMA BRONCHIOGENIC STAGE III trials appear

Can an immunotherapy cocktail shrink inoperable lung tumors?